Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 18, 2025 07:00 ET | Source: Bionic Sight LLC

Bionic Sight’s BS01 Gene Therapy Receives RMAT Designation from the FDA

Company shares preliminary results from Phase 1/2 clinical trial for patients with advanced Retinitis Pigmentosa (RP) NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Bionic Sight, Inc., a company...